Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2010
12/23/2010WO2010146488A1 Bicyclic and tricyclic compounds as kat ii inhibitors
12/23/2010WO2010146348A2 New crystalline form of pemirolast
12/23/2010WO2010146104A1 Thiadiazole derivatives and their use for the treatment of disorders mediated by slpl receptors
12/23/2010WO2010146025A1 Tricyclic azabicyclo [4.1.0] heptane derivatives as inhibitors of serotonin, dopamine and norepinephrine re-uptake
12/23/2010WO2010145998A1 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
12/23/2010WO2010145883A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
12/23/2010WO2010145208A1 Diazahomoadamantane derivatives and methods of use thereof
12/23/2010WO2010095042A3 Pyridocarbazole type compounds and applications thereof
12/23/2010WO2010052161A3 Herbicidal compositions
12/23/2010US20100324294 Process for the preparation of 2,3,4,9-tetrahydro-1h-beta-carbolin-3-carboxylic acid esters
12/23/2010US20100324293 Monofunctionalized Perylenetetracarboxylic Acid Bismides
12/23/2010US20100324082 ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS
12/23/2010US20100324072 Pyrrolopyridine derivatives and their use as bace inhibitors
12/23/2010US20100324065 Compounds and methods for development of Ret Modulators
12/23/2010US20100324055 Solid states forms of varenicline salts and processes for preparation thereof
12/23/2010US20100324054 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/23/2010US20100324052 Novel piperidine carboxylic acid amine derivatives
12/23/2010US20100324049 Diaryl ketimine derivative having antagonism against melanin-concentrating hormone receptor
12/23/2010US20100324043 Bicyclic And Tricyclic Compounds As KAT II Inhibitors
12/23/2010US20100324042 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
12/23/2010US20100324040 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyrazol-3-yl) -3h-imidazo[4,5-b] pyridin-5- amine derivatives and their use for the treatment of cancer
12/23/2010US20100324036 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
12/23/2010US20100324035 Carboxamide Compounds and Their Use
12/23/2010US20100324028 Novel compounds
12/23/2010US20100324024 Quinolizidinone M1 Receptor Positive Allosteric Modulators
12/23/2010US20100324021 (dihydro)imidazoiso[5,1-a]quinolines
12/23/2010US20100324009 Substituted Sulfonamide Compounds
12/23/2010US20100322901 5, 6-ring annulated indole derivatives and use thereof
12/23/2010US20100319778 Perylene semiconductors and methods of preparation and use thereof
12/23/2010CA2765466A1 Diazahomoadamantane derivatives and methods of use thereof
12/23/2010CA2765415A1 Substituted -1,3,8-triazaspiro[4.5]decane-2,4-diones
12/23/2010CA2765408A1 New crystalline form of pemirolast
12/23/2010CA2763960A1 Bicyclic and tricyclic compounds as kat ii inhibitors
12/23/2010CA2755467A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
12/22/2010EP2264033A1 3,5-DIPHENYL-SUBSTITUTED PYRROLO[2,3b]PYRIDINES USEFUL AS KINASE INHIBITORS
12/22/2010EP2264032A2 Hiv protease inhibiting sulfonamides
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2263669A1 Pharmaceutically active isoindoline derivatives
12/22/2010EP2262805A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262804A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2- a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262803A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262784A1 Inhibitors of the chemokine receptor cxcr3
12/22/2010EP2262780A2 Amorphous varenicline tartrate
12/22/2010EP2262769A1 Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-a]pyridine derivatives, and preparation and therapeutic use thereof
12/22/2010EP2262505A2 Substituted heterocycle fused gamma-carbolines solid
12/22/2010EP2178873B1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors
12/22/2010EP1891066B1 Compounds and compositions as protein kinase inhibitors
12/22/2010CN1988907B Dual small molecule inhibitors of cancer and angiogenesis
12/22/2010CN1809357B Small molecule Toll-like receptor (TLR) antagonists
12/22/2010CN101925601A Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and pharmaceutical composition comprising it - 026
12/22/2010CN101925383A Carboxamide compounds and their use as chemokine receptor agonists
12/22/2010CN101921279A Spirocyclic heterocyclic derivatives and methods of their use
12/22/2010CN101921272A Method for extracting and separating laburnine
12/22/2010CN101921271A Pyridine [2,3-d] pyrimidone compounds and application thereof to pharmacy
12/22/2010CN101921268A 5-thiazole amide compound and biology application thereof
12/22/2010CN101921229A Synthesis method of stepholidine or derivative optical isomer thereof and intermediate thereof
12/22/2010CN101445507B Method for preparing praziquantel
12/22/2010CN101367823B Method for separating citrate, evodiamine and rutaecarpine from evodia rutaecarpa
12/22/2010CN101302227B Method for synthesizing 3,3'-purrocoline compounds
12/22/2010CN101302217B Triazole compounds, preparation and use thereof
12/22/2010CN101208340B Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1
12/22/2010CN101137656B Crystal forms of an imidazole derivative
12/22/2010CN101128461B Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors
12/22/2010CN101048406B Novel substituted imidazole derivatives
12/22/2010CA2708723A1 Solid states forms of varenicline salts and processes for preparation thereof
12/21/2010US7855295 Tetrahydrocarboline compounds as anticancer agents
12/21/2010US7855294 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
12/21/2010US7855216 e.g. 3-(4-Bromo-2-fluoro-phenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridine-2-carboxylic acid ethyl ester; MEK kinase (Mitogen-Activated protein kinase kinase) inhibitor; anticarcinogenic, antiinflammatory agent; rheumatoid arthritis
12/21/2010US7855214 Autoimmune, inflammatory, proliferative, or hyperproliferative disease or an immunologically-mediated disease; inhibitors of the Tec family of non-receptor tyrosine kinases; compounds are quinazolino[3,2-a]quinazolin-12-ones
12/21/2010US7855206 antidiabetic agents such as (1S,2R,5S)-5-(2-Methyl-6,8-dihydro-7H-pyrazolo[1,5-a]pyrrolo[3,4-e]pyrimidin-7-yl)-2-(2,4,5-trifluorophenyl)cyclohexanamine bis-hydrochloride salt, used for treating non-insulin dependent diabetes
12/21/2010US7855202 useful in the treatment respiratory system disorders, allergic diseases, inflammation, reperfusion injury, ischemia, atherosclerosis, hypertension, retinopathy, diabetes, gastrointestinal disorders and/or autoimmune diseases
12/21/2010US7855198 Benzamide derivative or salt thereof
12/21/2010US7855194 Pyrimidine, quinazoline, pteridine and triazine derivatives
12/21/2010CA2543201C ((ir, 3s)-3-isopropyl-3-{ [3-(trifluoromethyl)-7, 8-dihydro-1, 6-naphthyridin-6 (5h)-yl] carbonyl} cyclopentyl) [(3s, 4s)-3-methoxytetrahydro-2h-pyran-4-yl] amine succinate salt, composition thereof, and its use in the treatment of inflammatory diseases
12/21/2010CA2480046C Improved method of making nevirapine
12/21/2010CA2426654C 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds
12/21/2010CA2404594C Agent for prophylaxis and treatment of renal disease
12/16/2010WO2010144647A1 Nicotinamide compounds useful as kinase modulators
12/16/2010WO2010144486A1 Dihydropyrrolonaphtyridinone compounds as inhibitors of jak
12/16/2010WO2010144416A1 SUBSTITUTED PYRAZOLO [1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITY
12/16/2010WO2010143733A1 Novel fused cyclic compound and use thereof
12/16/2010WO2010143664A1 Tetracyclic compound
12/16/2010WO2010142974A1 mCPP IMMUNOASSAY
12/16/2010WO2010142628A1 Pyrazole oxadiazole derivatives as s1p1 agonists
12/16/2010WO2010142576A1 Novel sterically hindered amine light stabilizers
12/16/2010WO2010142426A1 Hedgehog pathway antagonists and therapeutic applications thereof
12/16/2010WO2010142402A1 Substituted benzimidazoles, benzothiazoles and benzoxazoles
12/16/2010WO2010116122A3 Herbicidal quinoline and 1,8 -naphthyridine compounds
12/16/2010US20100317689 Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
12/16/2010US20100317688 2-HETEROAROYLIMIDAZOL[1,2-a]PYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317687 2-BENZOYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
12/16/2010US20100317686 N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317685 N-PHENYL-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
12/16/2010US20100317684 Amide and Carbamate Derivatives of N-{2-[4-Amino-2- (Ethoxymethyl)-1H-Imidazo[4,5-c] Quinolin-1-Yl]-1,1-Dimethylethyl} Methanesulfonamide and Methods
12/16/2010US20100317676 Fused heterocyclic compounds, and compositions and uses thereof
12/16/2010US20100317675 6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317673 N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
12/16/2010US20100317672 Monomaleate Monohydrate Salt of a 5HT1A Receptor Antagonist
12/16/2010US20100317667 1-aryl-or 1-heteroaryl-pyrido[B]indoles and uses thereof
12/16/2010US20100317660 Mediators of hedgehog signaling pathways, compositions and uses related thereto